Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Shintaro Saito"'
Autor:
Sayaka Toki, Sei-ichiro Motegi, Masahito Yasuda, Akihiko Uchiyama, Yukie Endo, Mayu Nishio, Yoshinao Muro, Shintaro Saito, Akihito Uehara, Osamu Ishikawa
Publikováno v:
The Journal of Dermatology. 49:294-298
A 37-year-old Japanese man with a 3-year history of diffuse cutaneous systemic sclerosis was admitted to our hospital with high fever, arthralgia, myalgia, and muscle weakness. A physical examination revealed facial erythema, Gottron's sign, and mech
Autor:
Seigo Kinuya, Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Shintaro Saito, Anri Inaki, Yuji Kunita, Takafumi Yamase, Satoru Watanabe, Norihito Akatani, Daiki Kayano
Publikováno v:
Annals of Nuclear Medicine. 36:61-69
OBJECTIVE Given the rarity of refractory pheochromocytoma and paraganglioma (PPGL), outcomes and prognostic factors after 131I-metaiodobenzylguanidine (131I-mIBG) treatment still remain unclear. Therefore, this study evaluated whether baseline charac
Publikováno v:
EJNMMI Research, Vol 11, Iss 1, Pp 1-11 (2021)
EJNMMI Research
EJNMMI Research
Background Since three-dimensional segmentation of cardiac region in 123I-metaiodobenzylguanidine (MIBG) study has not been established, this study aimed to achieve organ segmentation using a convolutional neural network (CNN) with 123I-MIBG single p
Publikováno v:
Annals of Nuclear Medicine. 35:649-661
To evaluate the detecting capability between planar imaging (PI) and PI combined with single-photon emission computed tomography/computed tomography (PICWS), including 123I- and 131I-labeled metaiodobenzylguanidine (mIBG) and to compare the detecting
Autor:
Yukiko Teramoto, Yasuhiro Fujisawa, Kentaro Yamamura, Yasuhiro Nakamura, Ryuichiro Araki, Shintaro Saito, Shigeto Matsushita, Takaya Komori, Akiha Inoue, Megumi Aoki, Ryota Tanaka, Yoshiyuki Nakamura, Manabu Yoshioka
Publikováno v:
Journal of Dermatological Science. 99:152-157
Basal cell carcinoma (BCC) is the most common skin cancer. While Mohs micrographic surgery is commonly accepted for BCC treatment, surgical excision with free margins is widely considered the best treatment modality for BCCs in Japan. However, little
Autor:
Hiroshi Mori, Rie Kuroda, Raita Araki, Seigo Kinuya, Taizo Wada, Anri Inaki, Takafumi Yamase, Satoru Watanabe, Toshihiro Fujiki, Norihito Akatani, Shintaro Saito, Ryosei Nishimura, Hiroshi Wakabayashi, Yuji Kunita, Yasuhiro Ikawa, Tomo Hiromasa, Daiki Kayano
Publikováno v:
Annals of Nuclear Medicine. 34:840-846
Children with relapsed neuroblastoma have a poor prognosis despite modern multimodality therapy. Novel and more effective therapeutic strategies are required for relapsed neuroblastoma. We retrospectively examined the utility of consolidation therapy
Publikováno v:
Journal of Coronary Artery Disease. 26:82-90
Autor:
Takeo Maekawa, Satoshi Fukushima, Taiki Isei, Takehiro Onuma, Naoya Yamazaki, Takashi Inozume, Natsuki Baba, Hiroshi Kato, Osamu Yamasaki, Yasuo Nakai, Yoshiyasu Umeda, Shusuke Yoshikawa, Kotaro Nagase, Taisuke Matsuya, Shigeto Matsushita, Atsushi Otsuka, Takahide Kaneko, Motoo Nomura, Masazumi Onishi, Yasuhiro Nakamura, Yutaka Kuwatsuka, Noriki Fujimoto, Kenjiro Namikawa, Tatsuya Takenouchi, Yukiko Kiniwa, Shintaro Saito, Ryo Tanaka
Publikováno v:
European journal of cancer (Oxford, England : 1990). 157
Background Immune checkpoint inhibitors (ICIs) have a lower efficacy in mucosal melanoma (MUM) than in cutaneous melanoma. The use of combination treatments with radiotherapy (RT) to improve the efficacy in MUM, however, requires further investigatio
Autor:
Sei-ichiro Motegi, Shintaro Saito, Akiko Sekiguchi, Mayu Nishio, Yukie Endo, Akihito Uehara, Osamu Ishikawa, Sahori Yamazaki, Keiji Kosaka
Publikováno v:
The Journal of Dermatology. 48
Autor:
Shintaro Saito, Y. Umeda, Yukiko Kiniwa, Yukiko Teramoto, Takashi Inozume, N. Yamazaki, Dai Ogata, Satoshi Fukushima, Noriki Fujimoto, Osamu Yamasaki, Tatsuya Takenouchi, Yasuo Nakai, A. Takahashi, Ryo Tanaka, Yasuhiro Nakamura, S. Yoshikawa, Takehiro Onuma, M. Otsuka, Kotaro Nagase, Yutaka Kuwatsuka, S. Matsushita, Natsuki Baba, Taisuke Matsuya, Motoo Nomura, Kenjiro Namikawa, Taiki Isei, Takahide Kaneko, Masazumi Onishi, Hiroshi Kato, Takeo Maekawa, Atsushi Otsuka
Publikováno v:
ESMO Open
Background Anti-programmed cell death protein 1 (PD-1) antibody monotherapy (PD1) has led to favorable responses in advanced non-acral cutaneous melanoma among Caucasian populations; however, recent studies suggest that this therapy has limited effic